Wash. Judge Won't Stop Actos Generic For Mylan Appeal
Mylan Pharmaceuticals Inc. on Tuesday lost its bid to block Watson Laboratories Inc.'s production of a generic version of diabetes drug Actos while it appeals to the D.C. Circuit a Washington...To view the full article, register now.
Already a subscriber? Click here to view full article